Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Galina I. Buravchenko
Observed names:
Andrey E. Shchekotikhin,
Buravchenko, Galina I.,
G. Buravchenko,
G.I. Buravchenko,
Galina I Buravchenko
Institution:
Gause Institute of New Antibiotics Russian Academy of Medical Sciences
Observed institutions:
D. Mendeleyev University of Chemical Technology of Russia,
Gause Institute of New Antibiotics Russian Academy of Medical Sciences
ORCID:
0000-0003-4940-9686
Observed ORCID:
0000-0003-4940-9686
OpenAlex ID:
A5023902397
Novel Quinoxaline-2-Carbonitrile-1,4-Dioxide Derivatives Suppress HIF1α Activity and Circumvent MDR in Cancer Cells
2018
·
Alexander M. Scherbakov
, Alexander M. Borunov
, et al.
·
Cancer Investigation
·
21
Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development
2023
·
Galina I. Buravchenko
, Andrey E. Shchekotikhin
·
Pharmaceuticals
·
17
PDF
Novel Derivatives of Quinoxaline-2-carboxylic Acid 1,4-Dioxides as Antimycobacterial Agents: Mechanistic Studies and Therapeutic Potential
2023
·
Svetlana G. Frolova
, Aleksey A. Vatlin
, et al.
·
Pharmaceuticals
·
14
PDF
In Vitro Pharmacological Screening of Essential Oils from Baccharis parvidentata and Lippia origanoides Growing in Brazil
2022
·
Wilmer H. Perera
, Alexander M. Scherbakov
, et al.
·
Molecules
·
13
PDF
Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency
2020
·
Galina I. Buravchenko
, Alexander M. Scherbakov
, et al.
·
Bioorganic Chemistry
·
13
Synthesis and Characterization of Novel 2-Acyl-3-trifluoromethylquinoxaline 1,4-Dioxides as Potential Antimicrobial Agents
2022
·
Galina I. Buravchenko
, Dmitry A. Maslov
, et al.
·
Pharmaceuticals
·
11
PDF
Revision of the Regioselectivity of the Beirut Reaction of Monosubstituted Benzofuroxans with Benzoylacetonitrile. 6-Substituted quinoxaline-2-carbonitrile 1,4- dioxides: Structural Characterization and Estimation of Anticancer Activity and Hypoxia Selectivity
2019
·
Galina I. Buravchenko
, Alexander M. Scherbakov
, et al.
·
Current Organic Synthesis
·
9
Synthesis and evaluation of sulfonamide derivatives of quinoxaline 1,4-dioxides as carbonic anhydrase inhibitors
2024
·
Galina I. Buravchenko
, Alexander M. Scherbakov
, et al.
·
RSC Advances
·
8
PDF
Synthesis of 7-amino-6-halogeno-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: a way forward for targeting hypoxia and drug resistance of cancer cells
2021
·
Galina I. Buravchenko
, Alexander M. Scherbakov
, et al.
·
RSC Advances
·
8
PDF
Revisiting heliomycin: Chemistry, biological activity, and perspectives for drug development
2026
·
Galina I. Buravchenko
, Alexander S. Tikhomirov
, et al.
·
European Journal of Medicinal Chemistry
·
2
48P Low glucose sensitizes A431 skin cancer cells to metformin treatments: A way forward to targeting PD-L1
2021
·
A.L. Mikhaylova
, A.A. Basharina
, et al.
·
Annals of Oncology
·
2
PDF
PO-413 Estimation of antitumor activity of amino derivatives of quinoxaline-2-carbonitrile 1,4-dioxide
2018
·
G. Buravchenko
, I. Treshchalin
, et al.
·
ESMO Open
·
1
Cationic side chain-functionalized heteroarene-fused anthraquinones as selective G-quadruplex stabilizers
2026
·
Daria V. Andreeva
, Vladimir B. Tsvetkov
, et al.
·
RSC Medicinal Chemistry
Synthesis of 2-sulfamoylquinoxaline 1,4-dioxide derivatives
2025
·
Galina I Buravchenko
, Andrey Egorovich Shchekotikhin
·
Mendeleev Communications
Author response for "Synthesis and evaluation of sulfonamide derivatives of quinoxaline 1,4-dioxides as carbonic anhydrase inhibitors"
2024
·
Galina I. Buravchenko
, Alexander M. Scherbakov
, et al.
·
Publons reviews and discussion
CCDC 2048057: Experimental Crystal Structure Determination
2020
·
Buravchenko, Galina I.
, Scherbakov, Alexander M.
, et al.
·
The Cambridge Structural Database
44P Novel insights into the pharmacological effects of hypoxic cytotoxins in hormone-dependent breast cancer cells: ERα degradation and modulation of ERK signaling activity
2020
·
A.M. Scherbakov
, G. Buravchenko
, et al.
·
Annals of Oncology
32P Evaluation of novel hypoxia-selective antitumor agents blocking HIF-1α/CA9 axis in breast cancer
2020
·
G.I. Buravchenko
, A.M. Scherbakov
, et al.
·
Annals of Oncology
Targeting HIF1α/AP1 in hypoxia by novel 7-amino-6-halogeno-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides
2019
·
A.M. Scherbakov
, G.I. Buravchenko
, et al.
·
Annals of Oncology
PO-411 Novel HIF1α inhibitors suppress cancer cell growth and circumvent multidrug resistance
2018
·
A. Scherbakov
, G. Buravchenko
, et al.
·
ESMO Open
Show more works
View as search
Works count:
20
Citation count:
119
H-index:
8
I10-index:
6
Year
Topic
Type